Curis
CRIS
#10262
Rank
NZ$19.24 M
Marketcap
NZ$1.40
Share price
-8.58%
Change (1 day)
-72.34%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): NZ-$6.38

According to Curis's latest financial reports the company's current EPS (TTM) is NZ-$6.31. In 2024 the company made an earnings per share (EPS) of NZ-$12.08 an increase over its 2023 EPS that were of NZ-$15.52.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$6.38-47.17%
2024NZ-$12.08-22.15%
2023NZ-$15.52-26.17%
2022NZ-$21.0222.3%
2021NZ-$17.19-25.37%
2020NZ-$23.03-30.93%
2019NZ-$33.34-2.02%
2018NZ-$34.03
2016NZ-$77.34-10%
2015NZ-$85.93138.1%
2014NZ-$36.0940%
2013NZ-$25.78-25%
2012NZ-$34.3766.67%
2011NZ-$20.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.34-137.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.10-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ-$0.62-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$4.09-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$5.81-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ-$19.32 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$2.42-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA